Letter to the editor: Sitting as signal in cancer survivorship

To the Editor, Gou and Chen’s recent analysis links prolonged sitting and anemia to increased mortality in older cancer survivors[1]. While the association is statistically robust, its clinical significance may lie less in sedentary duration and more in the biological distress it reflects. This study complies with the TITAN 2025 guidelines for transparent and ethical reporting of AI-assisted research[2]. In cancer survivorship, sedentariness may function not as a lifestyle choice but as a visible expression of systemic exhaustion. Post-treatment trajectories are often shaped by chronic inflammation, mitochondrial dysfunction, sarcopenia, and autonomic dysregulation – all of which erode physiological reserve[3]. What manifests as prolonged sitting may, in fact, be a surrogate for impaired neuromuscular coordination, reduced oxygen utilization, and blunted immune tone. This perspective challenges the framing of sedentary behavior as merely a modifiable exposure. For many survivors, sitting may not reflect volitional inactivity, but rather a threshold state – where biological resilience is insufficient to sustain upright engagement[4]. In this light, sedentariness is not a behavioral confounder but a functional phenotype of systems collapse. This reconceptualization yields clinically actionable insights. Rather than uniformly promoting activity, we might treat sitting patterns as a diagnostic proxy – an early warning sign of physiological decline[5]. Integrated with real-time wearable data and anchored by biomarkers of muscle metabolism, inflammatory tone, and hemoglobin dynamics, sedentariness could serve as a noninvasive index of recovery failure, guiding individualized rehabilitative strategies[6]. In this light, Gou and Chen have not simply identified a behavioral risk factor, but revealed a physiological signal hiding in plain sight. Reframing sedentariness as a functional phenotype unlocks a non-invasive biomarker of recovery failure – one that may guide precision monitoring and tailored interventions throughout the survivorship continuum.HIGHLIGHTS Proposes a paradigm shift by reinterpreting sedentariness in cancer survivors as a functional phenotype rather than a behavioral lapse. Links prolonged sitting to physiological exhaustion, including chronic inflammation, sarcopenia, and impaired neuromuscular resilience. Suggests sedentary behavior may serve as a non-invasive biomarker for post-treatment systemic decline and recovery failure. Advocates for integration of wearable data and biomarkers to stratify risk and personalize rehabilitation in survivorship care. Reframes stillness as a silent biological signal, inviting new approaches to monitoring, triaging, and supporting cancer survivors.